Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of USP7 mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of USP7 mRNA | affects expression | 21346803
|
C035207 |
4-amino-2,6-dinitrotoluene |
4-amino-2,6-dinitrotoluene affects the expression of USP7 mRNA | affects expression | 21346803
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of USP7 mRNA | decreases expression | 19150397
|
D002101 |
Cacodylic Acid |
Cacodylic Acid results in increased expression of USP7 mRNA | increases expression | 17720352
|
D003561 |
Cytarabine |
Cytarabine results in decreased expression of USP7 mRNA | decreases expression | 19194470
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of USP7 mRNA | increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of USP7 mRNA | affects cotreatment|increases expression | 17942748
|
C058305 |
phenethyl isothiocyanate |
phenethyl isothiocyanate results in decreased expression of USP7 mRNA | decreases expression | 17616710
|
C020806 |
tetrabromobisphenol A |
tetrabromobisphenol A affects the expression of USP7 mRNA | affects expression | 18976794
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of USP7 mRNA | affects cotreatment|increases expression | 17942748
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
4-amino-2,6-dinitrotoluene |
9.28 | 7525203 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
9.28 | 14514962 15322242 11752688 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.21 | 17505938 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
1.85 | 14692618 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.61 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.11 | 11748828 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.68 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.76 | 15885639 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.21 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.06 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.87 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Cacodylic Acid |
2.45 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.45 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.93 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
3.03 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
3.03 | 16705839 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.45 | 18670907 18850075 16120746 |
MESH:D002386 |
Cataract |
|
4-amino-2,6-dinitrotoluene |
3.72 | 14694615 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
12.05 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
12.05 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cytarabine |
12.05 | 8243401 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.31 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
3.00 | 17681005 11677210 16919318 17333356 16105132 15861022 17110522 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.16 | 8697196 15668235 16354765 12621046 15340226 |
MESH:D003093 |
Colitis, Ulcerative |
|
phenethyl isothiocyanate |
3.69 | 20423518 |
MESH:D000013 |
Congenital Abnormalities |
|
4-amino-2,6-dinitrotoluene |
9.70 | 15095906 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
9.70 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 10048152 15322242 20055451 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
11.63 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
11.63 | 18551238 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.70 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
9.37 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
9.37 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4-amino-2,6-dinitrotoluene |
9.37 | 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
9.37 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.89 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.55 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.17 | 18230668 16714409 15322242 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
3.38 | 12538720 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.18 | 10568697 9294722 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.11 | 20426865 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.14 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
2.98 | 15345470 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.67 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.16 | 20067830 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.86 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.41 | 11294989 10048152 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.51 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.11 | 12621046 16120746 15340226 |
MESH:D006689 |
Hodgkin Disease |
|
Cytarabine |
4.57 | 16200630 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.31 | 15340226 18606429 8697196 16354765 16959395 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.96 | 18850075 18670907 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
4.02 | 16569931 16945680 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.65 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.59 | 17937319 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.93 | 12878042 12200463 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.51 | 16580747 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
7.85 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
7.85 | 16705839 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
1.24 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
4.56 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
4.56 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
6.07 | 6135515 2876784 2876786 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
6.07 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
1.24 | 19555203 11884234 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.16 | 12213967 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
11.15 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
11.15 | 18551238 7678174 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.41 | 14600291 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
16.12 | 16049721 12819281 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
16.12 | 16049721 |
MESH:D009784 |
Occupational Diseases |
|
4-amino-2,6-dinitrotoluene |
16.12 | 14694615 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.87 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.51 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.76 | 18163543 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cytarabine |
4.53 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.43 | 11222880 11896295 11399792 11118676 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.55 | 15861022 16919318 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.04 | 18990726 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
6.25 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
6.25 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.11 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
4.21 | 16709447 |
MESH:D013733 |
Testicular Diseases |
|
phenethyl isothiocyanate |
5.18 | 15864552 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.80 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.30 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.17 | 12697716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
8.83 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
8.83 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cacodylic Acid |
8.83 | 15537745 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
12.80 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
12.80 | 10091137 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.50 | 14692618 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.86 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.71 | 15869587 14671159 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.51 | 15886252 |